NEWS
Eumedica concludes an exclusive distribution agreement of the Temgesic® outside North America
08/09/2021We are proud to announce that we recently concluded an exclusive distribution agreement of the TEMGESIC®/ BUPREX® / BUPREXX® (Buprenorphine – Sublingual Tablets & Injections) outside North America. With this new addition…
Eumedica increases its storage capacity
12/08/2021After announcing our warehouse expansion in January, we are proud to inform you that we are increasing our storage capacity thanks to the acquisition of a 1000m² warehouse. This new…
Our warehouse extension is growing fast !
14/07/2021It sounds like yesterday we announced the extension of our warehouse. Times flies and major milestones have been accomplished since January. Today, we’re happy to share with you some new…
Today, we are celebrating the 6th edition of the International Day of Women and Girls in Science. This annual international day has been established to recognize the critical role women…
+2000 followers on LinkedIn!
29/01/2021Eumedica is thrilled to have reached the oustanding milestone of having more than 2000 followers on LinkedIn. We want to warmly thank everyone who is engaging with our page and…
Eumedica announces new warehouse extension
20/01/2021In order to meet constant growing demand, we are proud to announce the extension of our warehouse floor space from 7000sqm to 10000sqm. This exciting development is set to provide…
Eumedica is granted AEO status
18/01/2021We are committed to our ethos of ensuring medical care continuity and bringing vital medicines to care-givers and patients throughout the world. To this end, we have recently been approved…
